Two specific matrix metalloproteinase (MMP) proteins have been found to contribute to bone metastasis in advanced breast cancer — lending important new insight into the design of clinically useful small molecule inhibitors.
Two specific matrix metalloproteinase (MMP) proteins have been found to contribute to bone metastasis in advanced breast cancer — lending important new insight into the design of clinically useful small molecule inhibitors.